74 related articles for article (PubMed ID: 16331630)
1. Silencing of APAF-1 in B-CLL results in poor prognosis in the case of concomitant p53 mutation.
Sturm I; Bosanquet AG; Radetzki S; Hummel M; Dörken B; Daniel PT
Int J Cancer; 2006 May; 118(9):2329-36. PubMed ID: 16331630
[TBL] [Abstract][Full Text] [Related]
2. In B-CLL, the codon 72 polymorphic variants of p53 are not related to drug resistance and disease prognosis.
Sturm I; Bosanquet AG; Hummel M; Dörken B; Daniel PT
BMC Cancer; 2005 Aug; 5():105. PubMed ID: 16109171
[TBL] [Abstract][Full Text] [Related]
3. Frequent DAP kinase but not p14 or Apaf-1 hypermethylation in B-cell chronic lymphocytic leukemia.
Chim CS; Fung TK; Wong KF; Lau JS; Liang R
J Hum Genet; 2006; 51(9):832-838. PubMed ID: 16897188
[TBL] [Abstract][Full Text] [Related]
4. A subset of chronic lymphocytic leukemia patients display reduced levels of PARP1 expression coupled with a defective irradiation-induced apoptosis.
Bacalini MG; Tavolaro S; Peragine N; Marinelli M; Santangelo S; Del Giudice I; Mauro FR; Di Maio V; Ricciardi MR; Caiafa P; Chiaretti S; Foà R; Guarini A; Reale A
Exp Hematol; 2012 Mar; 40(3):197-206.e1. PubMed ID: 22120020
[TBL] [Abstract][Full Text] [Related]
5. APAF-1 signaling in human melanoma.
Anichini A; Mortarini R; Sensi M; Zanon M
Cancer Lett; 2006 Jul; 238(2):168-79. PubMed ID: 16095810
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase activity regulates apaf-1 and caspase 3 expression in the developing mouse retina.
Wallace DM; Donovan M; Cotter TG
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2765-72. PubMed ID: 16799012
[TBL] [Abstract][Full Text] [Related]
7. Regularly methylated novel pro-apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder.
Christoph F; Weikert S; Kempkensteffen C; Krause H; Schostak M; Miller K; Schrader M
Int J Cancer; 2006 Sep; 119(6):1396-402. PubMed ID: 16642478
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma.
Soengas MS; Capodieci P; Polsky D; Mora J; Esteller M; Opitz-Araya X; McCombie R; Herman JG; Gerald WL; Lazebnik YA; Cordón-Cardó C; Lowe SW
Nature; 2001 Jan; 409(6817):207-11. PubMed ID: 11196646
[TBL] [Abstract][Full Text] [Related]
9. Overexpressed BAG3 is a potential therapeutic target in chronic lymphocytic leukemia.
Zhu H; Wu W; Fu Y; Shen W; Miao K; Hong M; Xu W; Young KH; Liu P; Li J
Ann Hematol; 2014 Mar; 93(3):425-35. PubMed ID: 23978946
[TBL] [Abstract][Full Text] [Related]
10. APAF-1 is a transcriptional target of p53 in DNA damage-induced apoptosis.
Robles AI; Bemmels NA; Foraker AB; Harris CC
Cancer Res; 2001 Sep; 61(18):6660-4. PubMed ID: 11559530
[TBL] [Abstract][Full Text] [Related]
11. Requirement of apoptotic protease-activating factor-1 for bortezomib-induced apoptosis but not for Fas-mediated apoptosis in human leukemic cells.
Ottosson-Wadlund A; Ceder R; Preta G; Pokrovskaja K; Grafström RC; Heyman M; Söderhäll S; Grandér D; Hedenfalk I; Robertson JD; Fadeel B
Mol Pharmacol; 2013 Jan; 83(1):245-55. PubMed ID: 23093495
[TBL] [Abstract][Full Text] [Related]
12. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D
Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742
[TBL] [Abstract][Full Text] [Related]
13. Bendamustine is effective in p53-deficient B-cell neoplasms and requires oxidative stress and caspase-independent signaling.
Roué G; López-Guerra M; Milpied P; Pérez-Galán P; Villamor N; Montserrat E; Campo E; Colomer D
Clin Cancer Res; 2008 Nov; 14(21):6907-15. PubMed ID: 18980985
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis protease activator protein-1 expression is dispensable for response of human melanoma cells to distinct proapoptotic agents.
Zanon M; Piris A; Bersani I; Vegetti C; Molla A; Scarito A; Anichini A
Cancer Res; 2004 Oct; 64(20):7386-94. PubMed ID: 15492260
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis in UV-C light irradiated p53 wild-type, apaf-1 and p53 knockout mouse embryonic fibroblasts: interplay of receptor and mitochondrial pathway.
Tomicic MT; Christmann M; Kaina B
Apoptosis; 2005 Dec; 10(6):1295-304. PubMed ID: 16215690
[TBL] [Abstract][Full Text] [Related]
16. TP53-induced glycolysis and apoptosis regulator protects from spontaneous apoptosis and predicts poor prognosis in chronic lymphocytic leukemia.
Hong M; Xia Y; Zhu Y; Zhao HH; Zhu H; Xie Y; Fan L; Wang L; Miao KR; Yu H; Miao YQ; Wu W; Zhu HY; Chen YY; Xu W; Qian SX; Li JY
Leuk Res; 2016 Nov; 50():72-77. PubMed ID: 27693855
[TBL] [Abstract][Full Text] [Related]
17. Targeting inhibitor of apoptosis proteins by Smac mimetic elicits cell death in poor prognostic subgroups of chronic lymphocytic leukemia.
Opel D; Schnaiter A; Dodier D; Jovanovic M; Gerhardinger A; Idler I; Mertens D; Bullinger L; Stilgenbauer S; Fulda S
Int J Cancer; 2015 Dec; 137(12):2959-70. PubMed ID: 26096065
[TBL] [Abstract][Full Text] [Related]
18. Mutation of p53 and consecutive selective drug resistance in B-CLL occurs as a consequence of prior DNA-damaging chemotherapy.
Sturm I; Bosanquet AG; Hermann S; Güner D; Dörken B; Daniel PT
Cell Death Differ; 2003 Apr; 10(4):477-84. PubMed ID: 12719725
[TBL] [Abstract][Full Text] [Related]
19. Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIF.
Huerta S; Heinzerling JH; Anguiano-Hernandez YM; Huerta-Yepez S; Lin J; Chen D; Bonavida B; Livingston EH
J Surg Res; 2007 Sep; 142(1):184-94. PubMed ID: 17603079
[TBL] [Abstract][Full Text] [Related]
20. Methylation silencing of the Apaf-1 gene in acute leukemia.
Furukawa Y; Sutheesophon K; Wada T; Nishimura M; Saito Y; Ishii H; Furukawa Y
Mol Cancer Res; 2005 Jun; 3(6):325-34. PubMed ID: 15972851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
